Chemours Company (CC) Stock Forecast & Price Target

Compare

1,304 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CC Analyst Ratings

Moderate Buy

6 Buy

5 Hold

0 Sell

Based on 11 analysts giving stock ratings to

Chemours

Company

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CC Stock 12 Month Forecast

Average Price Target

$15.05

▲(35.34%Upside)

Based on 11 Wall Street analysts offering 12 month price targets for Chemours Company in the last 3 months. The average price target is $15.05 with a high forecast of $20.00 and a low forecast of $11.50. The average price target represents a 35.34% change from the last price of $11.12.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"10":"$10","25":"$25","13.75":"$13.75","17.5":"$17.5","21.25":"$21.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":20,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$20.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.05,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$15.05</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$11.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[10,13.75,17.5,21.25,25],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Feb<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.1,12.707692307692307,13.315384615384616,13.923076923076923,14.53076923076923,15.138461538461538,15.746153846153845,16.353846153846156,16.96153846153846,17.56923076923077,18.176923076923078,18.784615384615385,19.392307692307693,{"y":20,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.1,12.326923076923077,12.553846153846154,12.78076923076923,13.007692307692308,13.234615384615385,13.461538461538462,13.688461538461539,13.915384615384616,14.142307692307693,14.36923076923077,14.596153846153847,14.823076923076924,{"y":15.05,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,12.1,12.053846153846154,12.007692307692308,11.961538461538462,11.915384615384616,11.86923076923077,11.823076923076924,11.776923076923076,11.73076923076923,11.684615384615384,11.638461538461538,11.592307692307692,11.546153846153846,{"y":11.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":24.48,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":23.58,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.49,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.14,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.72,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.98,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.16,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":21.12,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.49,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.53,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.83,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.86,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.1,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$20.00

Average Price Target$15.05

Lowest Price Target$11.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

TipRanks AITipRanks

Not Ranked

TipRanks

$10

Hold

-10.07%

Downside

Reiterated

06/05/25

Chemours Company faces significant financial challenges, particularly with high leverage and negative cash flows. Technical indicators suggest bearish momentum, and although the dividend yield is attractive, the high P/E ratio points to potential overvaluation. Earnings call insights reveal strategic advancements but also significant operational and financial hurdles.

Michael LeitheadBarclays

Barclays

$16→$13

Hold

16.91%

Upside

Reiterated

05/28/25

Barclays Sticks to Their Hold Rating for Chemours Company (CC)

Duffy FischerGoldman Sachs

Goldman Sachs

$21→$14

Hold

25.90%

Upside

Reiterated

05/14/25

Analysts Offer Insights on Materials Companies: Endeavour Silver (NYSE: EXK) and Chemours Company (NYSE: CC)

Jeffrey ZekauskasJ.P. Morgan

J.P. Morgan

$18→$13

Hold

16.91%

Upside

Reiterated

05/13/25

Chemours (CC) PT Lowered to $13 at JPMorganJPMorgan analyst Jeffrey Zekauskas lowered the price target on Chemours (NYSE: CC) to $13.00 (from $18.00) while maintaining a Neutral rating.

Vincent AndrewsMorgan Stanley

Morgan Stanley

$22→$15

Hold

34.89%

Upside

Reiterated

05/12/25

Chemours price target lowered to $15 from $22 at Morgan StanleyChemours price target lowered to $15 from $22 at Morgan Stanley

Pete OsterlandTruist Financial

Truist Financial

$22→$20

Buy

79.86%

Upside

Reiterated

05/12/25

Wall Street Analysts Are Bullish on Top Materials Picks

Laurence AlexanderJefferies

Jefferies

$20→$11.5

Hold

3.42%

Upside

Reiterated

05/08/25

Chemours (CC) PT Lowered to $11.50 at JefferiesJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $11.50 (from $20.00) while maintaining a Hold rating.

John Roberts CFAMizuho Securities

Mizuho Securities

$15→$13

Buy

16.91%

Upside

Reiterated

05/07/25

Chemours (CC) PT Lowered to $13 at MizuhoMizuho analyst John Roberts lowered the price target on Chemours (NYSE: CC) to $13.00 (from $15.00) while maintaining a Outperform rating.

John McNultyBMO Capital

BMO Capital

$21→$17

Buy

52.88%

Upside

Reiterated

05/07/25

BMO Capital Reaffirms Their Buy Rating on Chemours Company (CC)

Joshua SpectorUBS

UBS

$18→$17

Buy

52.88%

Upside

Reiterated

05/07/25

Chemours price target lowered to $17 from $18 at UBSChemours price target lowered to $17 from $18 at UBS

Arun ViswanathanRBC Capital

RBC Capital

$17→$14

Buy

25.90%

Upside

Reiterated

05/07/25

Analysts Offer Insights on Materials Companies: Chemours Company (NYSE: CC), Artemis Gold (Other OTC: ARGTF) and Rayonier Advanced Materials (NYSE: RYAM)

Hassan AhmedAlembic Global

Alembic Global

$27→$18

Buy

61.87%

Upside

Reiterated

05/06/25

Alembic Global Remains a Buy on Chemours Company (CC)

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

TipRanks AITipRanks

Not Ranked

TipRanks

$10

Hold

-10.07%

Downside

Reiterated

06/05/25

Michael LeitheadBarclays

Barclays

$16→$13

Hold

16.91%

Upside

Reiterated

05/28/25

Barclays Sticks to Their Hold Rating for Chemours Company (CC)

Duffy FischerGoldman Sachs

Goldman Sachs

$21→$14

Hold

25.90%

Upside

Reiterated

05/14/25

Analysts Offer Insights on Materials Companies: Endeavour Silver (NYSE: EXK) and Chemours Company (NYSE: CC)

Jeffrey ZekauskasJ.P. Morgan

J.P. Morgan

$18→$13

Hold

16.91%

Upside

Reiterated

05/13/25

Chemours (CC) PT Lowered to $13 at JPMorganJPMorgan analyst Jeffrey Zekauskas lowered the price target on Chemours (NYSE: CC) to $13.00 (from $18.00) while maintaining a Neutral rating.

Vincent AndrewsMorgan Stanley

Morgan Stanley

$22→$15

Hold

34.89%

Upside

Reiterated

05/12/25

Chemours price target lowered to $15 from $22 at Morgan StanleyChemours price target lowered to $15 from $22 at Morgan Stanley

Pete OsterlandTruist Financial

Truist Financial

$22→$20

Buy

79.86%

Upside

Reiterated

05/12/25

Wall Street Analysts Are Bullish on Top Materials Picks

Laurence AlexanderJefferies

Jefferies

$20→$11.5

Hold

3.42%

Upside

Reiterated

05/08/25

Chemours (CC) PT Lowered to $11.50 at JefferiesJefferies analyst Laurence Alexander lowered the price target on Chemours (NYSE: CC) to $11.50 (from $20.00) while maintaining a Hold rating.

John Roberts CFAMizuho Securities

Mizuho Securities

$15→$13

Buy

16.91%

Upside

Reiterated

05/07/25

Chemours (CC) PT Lowered to $13 at MizuhoMizuho analyst John Roberts lowered the price target on Chemours (NYSE: CC) to $13.00 (from $15.00) while maintaining a Outperform rating.

John McNultyBMO Capital

BMO Capital

$21→$17

Buy

52.88%

Upside

Reiterated

05/07/25

BMO Capital Reaffirms Their Buy Rating on Chemours Company (CC)

Joshua SpectorUBS

UBS

$18→$17

Buy

52.88%

Upside

Reiterated

05/07/25

Chemours price target lowered to $17 from $18 at UBSChemours price target lowered to $17 from $18 at UBS

Arun ViswanathanRBC Capital

RBC Capital

$17→$14

Buy

25.90%

Upside

Reiterated

05/07/25

Analysts Offer Insights on Materials Companies: Chemours Company (NYSE: CC), Artemis Gold (Other OTC: ARGTF) and Rayonier Advanced Materials (NYSE: RYAM)

Hassan AhmedAlembic Global

Alembic Global

$27→$18

Buy

61.87%

Upside

Reiterated

05/06/25

Alembic Global Remains a Buy on Chemours Company (CC)

Stocks with the Highest Top Analyst Consensus in the Basic Materials Sector

xxx

Find stocks in the Basic Materials sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Chemours Company

1 Month

xxx

Success Rate

11/20 ratings generated profit

Average Return

+1.93%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 55.00% of your transactions generating a profit, with an average return of +1.93% per trade.

3 Months

xxx

Success Rate

10/20 ratings generated profit

Average Return

+2.71%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +2.71% per trade.

1 Year

Hassan AhmedAlembic Global

Success Rate

9/20 ratings generated profit

Average Return

-2.33%

reiterated a buy rating last month

Copying Hassan Ahmed's trades and holding each position for 1 Year would result in 45.00% of your transactions generating a profit, with an average return of -2.33% per trade.

2 Years

xxx

Success Rate

8/23 ratings generated profit

Average Return

-21.90%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 34.78% of your transactions generating a profit, with an average return of -21.90% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CC Analyst Recommendation Trends

Rating

Jan 25

Feb 25

Mar 25

Apr 25

May 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CC has received 16 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. CC average Analyst price target in the past 3 months is 15.05.

Each month's total comprises the sum of three months' worth of ratings.

CC Financial Forecast

CC Earnings Forecast

Next quarter’s earnings estimate for CC is $0.52 with a range of $0.46 to $0.57. The previous quarter’s EPS was $0.13. CC beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 46.31% of the time in the same period. In the last calendar year CC has Outperformed its overall industry.

CC Sales Forecast

Next quarter’s sales forecast for CC is $1.56B with a range of $1.53B to $1.59B. The previous quarter’s sales results were $1.37B. CC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 46.40% of the time in the same period. In the last calendar year CC has Outperformed its overall industry.

CC Stock Forecast FAQ

What is CC’s average 12-month price target, according to analysts?

Based on analyst ratings, Chemours Company’s 12-month average price target is 15.05.

What is CC’s upside potential, based on the analysts’ average price target?

Chemours Company has 35.34% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is CC a Buy, Sell or Hold?

Chemours Company has a consensus rating of Moderate Buy which is based on 6 buy ratings, 5 hold ratings and 0 sell ratings.

What is Chemours Company’s price target?

The average price target for Chemours Company is 15.05. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $20.00 ,the lowest forecast is $11.50. The average price target represents 35.34% Increase from the current price of $11.12.

What do analysts say about Chemours Company?

Chemours Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 11 Wall Streets Analysts.

How can I buy shares of CC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Chemours Company (CC) Stock Forecast & Price Target

CC Analyst Ratings

CC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Chemours Company

CC Analyst Recommendation Trends

CC Financial Forecast

CC Earnings Forecast

CC Sales Forecast

CC Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts